Pamela J. Boimel, Ph.D. - Publications

2013 Yeshiva University, New York, NY, United States 
Cell Biology, Oncology

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Boimel PJ, Smirnova T, Zhou ZN, Wyckoff J, Park H, Coniglio SJ, Qian BZ, Stanley ER, Cox D, Pollard JW, Muller WJ, Condeelis J, Segall JE. Contribution of CXCL12 secretion to invasion of breast cancer cells. Breast Cancer Research : Bcr. 14: R23. PMID 22314082 DOI: 10.1186/bcr3108  0.36
2012 Smirnova T, Zhou ZN, Flinn RJ, Wyckoff J, Boimel PJ, Pozzuto M, Coniglio SJ, Backer JM, Bresnick AR, Condeelis JS, Hynes NE, Segall JE. Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis. Oncogene. 31: 706-15. PMID 21725367 DOI: 10.1038/onc.2011.275  0.36
2011 Zhou ZN, Boimel PJ, Segall JE. Tumor-stroma: In vivo assays and intravital imaging to study cell migration and metastasis. Drug Discovery Today. Disease Models. 8: 95-112. PMID 22081771 DOI: 10.1016/j.ddmod.2011.07.003  0.52
2011 Boimel PJ, Cruz C, Segall JE. A functional in vivo screen for regulators of tumor progression identifies HOXB2 as a regulator of tumor growth in breast cancer. Genomics. 98: 164-72. PMID 21672623 DOI: 10.1016/j.ygeno.2011.05.011  0.52
2009 Kedrin D, Wyckoff J, Boimel PJ, Coniglio SJ, Hynes NE, Arteaga CL, Segall JE. ERBB1 and ERBB2 have distinct functions in tumor cell invasion and intravasation. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 3733-9. PMID 19458057 DOI: 10.1158/1078-0432.CCR-08-2163  0.36
Show low-probability matches.